OpenBilldrug price receipt

NADAC week of 2026-10-14

PRISTIQ ER 50 MG TABLET

FDA nonproprietary name: desvenlafaxine succinate

For 30 tablets

Pharmacies pay

$418.90 filed

30 × $13.96336 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$486.74 estimated

$418.90 + $62.84 (15%) + $5.00 fee per fill = $486.74

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

PRISTIQ ER 50 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as desvenlafaxine succinate, under the trade name “Pristiq Extended-Release”.

FDA gives its dosage form as tablet, extended release and its route as oral.

The labeler, the company named on the label, is Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

FDA’s Established Pharmacologic Class for it is Serotonin and Norepinephrine Reuptake Inhibitor.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $418.90 for 30 tablets (30 × $13.96336 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $0.39649 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

All 3 NDCs

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name desvenlafaxine succinate with PRISTIQ ER 50 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
DESVENLAFAXINE SUCCNT ER 25 MG
generic · tablet, film coated, extended release / tablet, extended release
$0.39851 per EA filed
eff. 2026-09-23
$1.19746 per EA filed
Part D 2024 average
DESVENLAFAXINE SUCCNT ER 50 MG
generic · tablet, film coated, extended release / tablet, extended release
$0.39649 per EA filed
eff. 2026-09-23
$1.19746 per EA filed
Part D 2024 average
DESVENLAFAXINE SUCCNT ER 100 MG
generic · tablet, film coated, extended release / tablet, extended release
$0.4136 per EA filed
eff. 2026-09-23
$1.19746 per EA filed
Part D 2024 average
PRISTIQ ER 25 MG TABLET
brand · tablet, extended release
$13.973 per EA filed
eff. 2026-09-23
We don’t know yet
PRISTIQ ER 50 MG TABLET this page
brand · tablet, extended release
$13.96336 per EA filed
eff. 2026-09-23
We don’t know yet
PRISTIQ ER 100 MG TABLET
brand · tablet, extended release
$13.93397 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $13.96336 per EA filed.

Of the 43 other products in FDA’s Serotonin and Norepinephrine Reuptake Inhibitor class priced per EA, 8 have a higher middle NADAC price and 35 a lower one. The one in the middle is MILNACIPRAN HCL 50 MG TABLET, at $2.80179 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.